Prohibits health insurance carriers from denying coverage of nonopioid prescription drugs in favor of opioid prescription drugs.

New Jersey S4283 prohibits health insurance carriers from denying coverage of nonopioid prescription drugs in favor of opioid prescription drugs. The bill ensures that nonopioid drugs are not subjected to more restrictive coverage criteria, utilization controls, or higher cost-sharing responsibilities compared to opioid drugs. This applies to both the Department of Human Services and the State Health Benefits Commission. The provisions also extend to Medicaid and school employees' health benefits. The act takes effect on January 1, 2027.

Prohibits health insurance carriers from denying coverage of nonopioid prescription drugs in favor of opioid prescription drugs.

New Jersey S4283 prohibits health insurance carriers from denying coverage of nonopioid prescription drugs in favor of opioid prescription drugs. The bill ensures that nonopioid drugs are not subjected to more restrictive coverage criteria, utilization controls, or higher cost-sharing responsibilities compared to opioid drugs. This applies to both the Department of Human Services and the State Health Benefits Commission. The provisions also extend to Medicaid and school employees' health benefits. The act takes effect on January 1, 2027.